XRF Scientific (ASX:XRF) Risk Assessment


ASX:XRF XRF Scientific Ltd ASX:XRF
97 GF Score
Price A$1.77
GF Value A$1.65
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is XRF Scientific Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of XRF Scientific is: Low Risk: Strong fundamentals, worth long-term holding.

XRF Scientific  (ASX:XRF) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

XRF Scientific Risk Assessment Related Terms

ASX:XRF vs HON, MMM: Risk Assessment Comparison

For the Conglomerates subindustry, XRF Scientific's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

XRF Scientific Risk Assessment vs Conglomerates Industry

For the Conglomerates industry and Industrials sector, XRF Scientific's Risk Assessment distribution charts can be found below:

* The bar in red indicates where XRF Scientific's Risk Assessment falls into.


ASX:XRF
97GF Score
XRF Scientific Ltd ASX:XRF
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is XRF Scientific (ASX:XRF) Overvalued in 2026?

Based on GuruFocus' analysis, XRF Scientific stock appears to be overvalued. The current stock price of A$1.77 is trading 7.3% above its estimated GF Value™ of A$1.65. GuruFocus considers XRF Scientific to be Fairly Valued.

Key valuation signals for ASX:XRF:

  • Risk Assessment:
  • GF Value™: A$1.65 vs. price of A$1.77 (7.3% above fair value)
  • GF Score™: 97/100 with 1 warning sign

No single metric tells the full story. See the ASX:XRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

XRF Scientific Business Description

Address 86 Guthrie Street, Osborne Park, Perth, WA, AUS, 6017
XRF Scientific Ltd is engaged in the business of manufacturing and marketing precious metal products, specialized chemicals and instruments for the scientific, analytical and mining industries. It operates through the following segments: Capital Equipment, Precious Metals, and Consumables. The company generates maximum revenue from the Capital Equipment segment that Manufactures sample preparation products and analytical instruments. Geographically, it derives a majority of revenue from Australia and also has a presence in Canada and Europe. Some of its product includes Electric Fusion Machines; Fusion Flux; Crushing and Pulverising, platinum lab ware and others.
97GF Score

Get the complete analysis for ASX:XRF

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$1.77
Price
A$1.65
GF Value